Condition
Multiple Myeloma, Neoplasms clinical trials and research
Research outlook What's coming for Multiple myeloma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Multiple Myeloma, Neoplasms clinical trials that are recruiting, at sites in 2 countries (most in Egypt (1), United States (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Fenofibrate to prevent nerve damage from VRd (bortezomib/lenalidomide/dexamethasone) in multiple myeloma
This tests whether adding fenofibrate to standard VRd chemotherapy can reduce bortezomib-related peripheral neuropathy in adults newly diagnosed with multiple myeloma.
-
Social needs screening and connection program for Metro Detroit cancer survivors
This project will test whether cancer survivors in Metro Detroit can complete a social needs screening and be connected to community resources for food and digital access.
Related topics
Quick answers
How many Multiple Myeloma, Neoplasms clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Egypt (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.